• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Gap in depression treatment may exist in America

byShayna BejaimalandAnees Daud
August 30, 2016
in Chronic Disease, Psychiatry, Public Health
Reading Time: 3 mins read
Shared decision-making tool for antidepressants improves patient and physician satisfaction
Share on FacebookShare on Twitter

1. Based on a survey study, only one-third of participants who screened positive for depression were receiving treatment, whereas only one-third of participants who were being treated for depression screened positive for depression.

2. There currently exists a large gap in depression care in the US. Further study will be required to ensure that depression management appropriately meets each individual patient’s needs.

Evidence Rating Level: 3 (Average)

Study Rundown: Depression is very common in the United States. However, many adults may not be receiving adequate treatment according to their disease severity. Studies on this topic also show that the number of prescriptions for antidepressants has been rising. In order to gain increasing clarity on the management trends for depression in the US, this study performed a survey analysis of households to characterize treatment of adult depression.

Of those who screened positive for depression, fewer than one-third were receiving treatment (psychotherapy or antidepressant medication). However, of all those being treated for depression, only about one-third screened positive for depression. This national survey oversampled minorities and those with low socioeconomic status, which may have been a strength given that those subgroups are at increased risk of poor access to mental health care. Limitations included use of only self-reported data, which can be biased.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

Relevant Reading: Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: A systematic review and meta-analysis

In-Depth [cross-sectional study]: From 2012 to 2013, the household component of the Medical Expenditure Panel Surveys (MEPS) was gathered for analysis of depression management trends. The MEPS screened for depressed mood or anhedonia by using the Patient Health Questionnaire-2 (PHQ-2). Treatment for depression was defined as outpatient visits to psychotherapy or mental health counselling, or use of antidepressant, antipsychotic, mood stabilizer, or anxiolytic medications. Patients with bipolar disorder were excluded. Psychological distress was assessed in the MEPS with the Kessler 6 (K6) score with regards to the individual’s mental health symptoms in the last 30 days. Individuals were classified by age, race, sex, level of education, and income. All questionnaires within the MEPS have been internally validated. Statistical analysis included logistic regression.

Approximately 8.4% of adults had screen-positive depression. Screen positive depression was 5-times more likely in individuals in the lowest income group as compared to the highest income group. However, fewer than one-third of adults with screen-positive depression received depression treatment in the survey year. Approximately 79% of adults with screen-positive depression who did not receive treatment had made 1 or more medical visits. However, 8.1% of all adults received treatment for depression regardless of depression screen status. Of those treated, only 30% had screen-positive depression or had serious psychological distress (22%). Adults with serious psychological distress were more likely to receive care from a psychiatrist or other mental health specialist, were less likely to receive depression care from general medical professionals. They were also more likely to receive psychotherapy.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depression
Previous Post

Increased disability insurance participation linked with increased opioid-related mortality

Next Post

Prolonged DAPT following PCI linked to fewer ischemic events in patients with PAD

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Parents often unaware of adolescents’ suicidal thoughts
Psychiatry

Psychotherapy identified as most effective treatment for grief

February 2, 2026
Next Post
Prolonged DAPT following PCI linked to fewer ischemic events in patients with PAD

Prolonged DAPT following PCI linked to fewer ischemic events in patients with PAD

Microbe-rich environment associated with lower rates of asthma

Formoterol-budesonide combination therapy for asthma does not increase adverse events

Few high school students, young adults get HIV testing

Early ART therapy for HIV-1 linked to decreased transmission: The HPTN 052 trial

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.